abs438.txt	as	the	use	of	oral	chemotherapy	continues	to	rise		the	issue	of	patient	adherenceis	a	concerning	aspect	of	cancer	treatment		in	this	concurrent	prospective	andretrospective	study		we	assessed	oral	chemotherapy	adherence	in	patientsreceiving	their	prescriptions	at	an	institutional	specialty	pharmacy		with	anintegrated	oral	chemotherapy	program		the	primary	endpoint	is	medicationpossession	ratio		secondary	endpoints	include	self-reported	adherence	comparingsurvey	data	before	and	after	the	introduction	of	the	oral	chemotherapy	program	toassess	the	impact	of	the	comprehensive	pharmacy	services	provided		patientsreceiving	their	oral	chemotherapy	from	the	institutional	specialty	pharmacy	havea	mean	medication	possession	ratio	of	0	92		indicating	excellent	adherence	rates	the	oncology	clinical	pharmacist		in	collaboration	with	the	specialty	pharmacy	has	also	decreased	the	rates	of	patient-reported	non-adherence	
